title: Effects of Sutherlandia frutescens extracts on normal T-lymphocytes in vitro.
abstract: Sutherlandia frutescens (SF), a popular traditional medicinal plant found in various parts of southern Africa, is used for treatment or management of HIV/AIDS and other diseases including cancer. However, its toxicity profile has not been fully established. The aims of this study were to examine the effects of 70% ethanol (SFE) and deionised water (SFW) extracts on normal isolated human T cells. An experimental study on normal human lymphocytes treated with doses SF extract doses ranging from 0.25 to 2.5 mg/ml. Untreated, vehicle-treated (Ethanol) and camptothecin (CPT) treated normal T cells were used as controls. Induction of cell death, changes in intracellular ATP, caspase-3/-7 activity and nuclear changes were analysed using flow cytometry, luminometry and nuclear staining (Hoechst) respectively. The highest concentration (2.5 mg/ml) of SFE extract induced significant necrosis (95%), depletion of ATP (76%), and inhibition of caspase-3/-7 activity (11%) following a 24 hour incubation period (p< 0.001). The 2.5 mg/ml concentration of SFW showed the same trend but were less effective (necrosis- 26%, ATP- 91%, & caspase-3/-7- 15%). These effects showed a time-dependence over 48 hours of incubation, with high doses of SFE extracts eliminating viable cells by necrosis, depleting ATP levels and decreasing caspase-3/-7 activity (p< 0.001). The activity of SFE extract was independent of ethanol. The SFW extract dilutions were less toxic than the SFE extracts. Significant DNA fragmentation as demonstrated by Hoechst staining was also seen over 48-hour incubation for high doses of both types of SF extracts. These results showed that although high concentrations of SF extracts can be toxic to normal T cells in vitro, SFW fractions were relatively safe for use.
authors: Mycotoxin Research Unit, School of Medical Sciences, Faculty of Health Sciences, University of KwaZulu-Natal Durban, South Africa.
authors: Mlungisi
authors: M
authors: Ngcobo
authors: Nceba
authors: N
authors: Gqaleni
authors: Paul K
authors: PK
authors: Chelule
authors: Metse
authors: M
authors: Serumula
authors: Alain
authors: A
authors: Assounga
mesh_terms: D000255:Adenosine Triphosphate / Q000378:metabolism*; D053148:Caspase 3 / Q000378:metabolism; D053179:Caspase 7 / Q000378:metabolism; D053470:Caspases, Effector / Q000378:metabolism*; D016923:Cell Death / Q000187:drug effects; D053938:DNA Fragmentation; D004305:Dose-Response Relationship, Drug; D007887:Fabaceae / Q000009:adverse effects*; D006801:Humans; D009336:Necrosis / Q000139:chemically induced*; D008517:Phytotherapy; D010936:Plant Extracts / Q000009:adverse effects* / Q000627:therapeutic use; D013601:T-Lymphocytes / Q000187:drug effects*
chemical_list: D010936:Plant Extracts; D000255:Adenosine Triphosphate; D053148:Caspase 3; D053179:Caspase 7; D053470:Caspases, Effector
keywords: Sutherlandia frutescens; T lymphocytes; apoptosis; flow cytometry; luminometry; necrosis
references: J Ethnopharmacol. 2010 Mar 2;128(1):1-14
references: 20079412
references: Nutr J. 2005 May 31;4:19
references: 15927053
references: J Ethnopharmacol. 2007 Jun 13;112(2):312-8
references: 17433588
references: Lancet. 2001 Apr 14;357(9263):1190
references: 11323065
references: Rev Diabet Stud. 2004 Fall;1(3):145-9
references: 17491678
references: Anticancer Drugs. 2002 Mar;13(3):313-20
references: 11984075
references: Nat Med. 2005 Jul;11(7):725-30
references: 16015365
references: J Ethnopharmacol. 2005 Jan 4;96(1-2):113-9
references: 15588658
references: Cell Death Differ. 1997 Aug;4(6):429-34
references: 16465263
references: J Ethnopharmacol. 2005 Apr 8;98(1-2):163-70
references: 15763378
references: J Ethnopharmacol. 2009 Jul 6;124(1):45-60
references: 19527821
references: J Ethnopharmacol. 2004 Jul;93(1):9-19
references: 15182898
references: J Ethnopharmacol. 2004 Nov;95(1):1-5
references: 15374599
references: Autophagy. 2008 Feb;4(2):141-50
references: 17986870
references: J Ethnopharmacol. 2008 Oct 28;119(3):620-9
references: 18761068
references: J Exp Med. 1997 Apr 21;185(8):1481-6
references: 9126928